Literature DB >> 20729401

Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules.

Gengqian Zhang1, Sulei Xu, Yan Qian, Pingnian He.   

Abstract

Sphingosine-1-phosphate (S1P) has been demonstrated to enhance endothelial barrier function in vivo and in vitro. However, different S1P receptor subtypes have been indicated to play different or even opposing roles in the regulation of vascular barrier function. This study aims to differentiate the roles of endogenous endothelial S1P subtype receptors in the regulation of permeability in intact microvessels using specific receptor agonist and antagonists. Microvessel permeability was measured with hydraulic conductivity (L(p)) in individually perfused rat mesenteric venules. S1P-mediated changes in endothelial intracellular Ca(2+) concentration ([Ca(2+)](i)) was measured in fura-2-loaded venules. Confocal images of fluorescent immunostaining illustrated the spatial expressions of three S1P subtype receptors (S1P(R1-3)) in rat venules. The application of S1P (1 μM) in the presence of S1P(R1-3) inhibited platelet-activating factor- or bradykinin-induced permeability increase. This S1P effect was reversed only with a selective S1P(R1) antagonist, W-146, and was not affected by S1P(R2) or S1P(R3) antagonists JTE-013 and CAY-10444, respectively. S1P(R1) was also identified as the sole receptor responsible for S1P-mediated increases in endothelial [Ca(2+)](i). S1P(R2) or S1P(R3) antagonist alone affected neither basal L(p) nor platelet-activating factor-induced permeability increase. The selective S1P(R1) agonist, SEW-2871, showed similar [Ca(2+)](i) and permeability effect to that of S1P. These results indicate that, despite the presence of S1P(R1-3) in the intact venules, only the activation of endothelial S1P(R1) is responsible for the protective action of S1P on microvessel permeability and that endogenous S1P(R2) or S1P(R3) did not exhibit functional roles in the regulation of permeability under basal or acutely stimulated conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729401      PMCID: PMC2993214          DOI: 10.1152/ajpheart.00462.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels.

Authors:  Roger H Adamson; Rupinder K Sarai; Ariungerel Altangerel; Twanda L Thirkill; Joyce F Clark; Fitz-Roy E Curry
Journal:  Cardiovasc Res       Date:  2010-06-11       Impact factor: 10.787

3.  A novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cells.

Authors:  K Muraki; Y Imaizumi
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

4.  Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.

Authors:  M J Lee; S Thangada; K P Claffey; N Ancellin; C H Liu; M Kluk; M Volpi; R I Sha'afi; T Hla
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement.

Authors:  J G Garcia; F Liu; A D Verin; A Birukova; M A Dechert; W T Gerthoffer; J R Bamberg; D English
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

Authors:  Tsukasa Ohmori; Yutaka Yatomi; Makoto Osada; Fuminori Kazama; Toshiro Takafuta; Hitoshi Ikeda; Yukio Ozaki
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

7.  Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA.

Authors:  F L Minnear; S Patil; D Bell; J P Gainor; C A Morton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-12       Impact factor: 5.464

8.  PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction.

Authors:  R H Adamson; M Zeng; G N Adamson; J F Lenz; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-03-20       Impact factor: 4.733

9.  Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.

Authors:  M Germana Sanna; Jiayu Liao; Euijung Jo; Christopher Alfonso; Min-Young Ahn; Melissa S Peterson; Bill Webb; Sophie Lefebvre; Jerold Chun; Nathanael Gray; Hugh Rosen
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

10.  Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist.

Authors:  Makoto Osada; Yutaka Yatomi; Tsukasa Ohmori; Hitoshi Ikeda; Yukio Ozaki
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

View more
  24 in total

1.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  Sphingosine-1-phosphate induced contraction of bladder smooth muscle.

Authors:  Derek M Kendig; Alec K Matsumoto; Robert S Moreland
Journal:  Eur J Pharmacol       Date:  2013-10-10       Impact factor: 4.432

5.  Control of vascular permeability by adhesion molecules.

Authors:  Ingrid H Sarelius; Angela J Glading
Journal:  Tissue Barriers       Date:  2015-04-03

6.  Cortical Actin Dynamics in Endothelial Permeability.

Authors:  Patrick Belvitch; Yu Maw Htwe; Mary E Brown; Steven Dudek
Journal:  Curr Top Membr       Date:  2018-10-15       Impact factor: 3.049

7.  Attenuation by sphingosine-1-phosphate of rat microvessel acute permeability response to bradykinin is rapidly reversible.

Authors:  R H Adamson; R K Sarai; J F Clark; A Altangerel; T L Thirkill; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

8.  Microvascular permeability to water is independent of shear stress, but dependent on flow direction.

Authors:  R H Adamson; R K Sarai; A Altangerel; J F Clark; S Weinbaum; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-15       Impact factor: 4.733

9.  Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect.

Authors:  R H Adamson; J F Clark; M Radeva; A Kheirolomoom; K W Ferrara; F E Curry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

10.  Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding.

Authors:  Ye Zeng; Roger H Adamson; Fitz-Roy E Curry; John M Tarbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.